Interferon Tedavisi Ile Basarili Bir Sekilde Tedavi Edilen Bir Kabakulak Orsiepididimit Olgusu

Kabakulak genellikle kendi kendini sinirlayan bir hastalik olarak bilinmesine karsin özellikle adölesan ve genç eriskinlerde orsiepididimite neden oldugunda testiküler atrofi ve dolayisiyla infertilite ile sonuçlanabilmektedir. Yaygin kabul gören bir tedavi seçecegi olmamakla birlikte genelde kullanilan tedaviler genis etki spektrumlu antibiyotikler, analjezik-antienflamatuvar tedavi, testis elevasyonu ve testislere buz tatbik edilmesidir. Ancak tüm bu tedavilerin testis atrofisini engelleyememesi nedeniyle bu tedavilere ek olarak kullanilacak interferon tedavisinin testis atrofisini engelleyebilecegi belirtilmektedir (1). Bu yazida, 14 yasindaki erkek olguda kabakulak enfeksiyonundan yaklasik 1 hafta sonra gelisen orsiepididimit olgusunda testis atrofisi ve infertilite riskini en aza indirmek amaciyla 7 günlük interferon alfa (Roferon, Roche) tedavisi ile basarili bir sekilde tedavi edilen ve herhangi bir yan etki gelistirmeyen bir olgu sunuldu

Anahtar Kelimeler:

Kabakulak, orsiepididimit, tedavi, interferon

A Case Report of Mumps Orchiepididymitis Treated Successfully With Alpha Interferon

Although mumps is known to be a self-limiting disease, it can result in testicular atrophy and infertility when it causes orchiepididymitis as a complication in adolescents and young adults. Although not commonly accepted treatment choices, generally used therapies include broad-spectrum antibiotics, analgesic-anti-inflammatory drugs, elevation of testicles and rest. But since these therapies can not prevent the occurrence of testicular atrophy, it is reported that additional interferon therapy may prevent testicular atrophy (1). In this case report, a 14 years old boy having developed orchiepididymitis one week after mumps infection was presented who was treated with interferon alpha (Roferon, Roche) for 7 days successfully and had no side effects

Keywords:

Mumps, orchiepididymitis, treatment, interferon,

PDF

___

Ku JH, Kim YH, Jeon YS, Lee NK. The preventive effect of systemic treatment with interferon-alpha2B for infertility from mumps orchitis. BJU Int. 84: 839-42. 1999
Overman JR. Viremia in human mumps virus infections. Arch Intern Med; 102:354. 1958
Weller TH, Craig JR. Isolation of mumps virus at autopsy. Am J Pathol 25:1105. 1949
Freeman BA: Mumps virus, in Textbook of Microbiology, 21st ed. Philadelphia, WB Saunders, pp 1001–1003. 1979
Bjorvatn B. Mumps virus isolated from testicles by fine-needle aspiration biopsy in cases of mumps orchitis. Scand J Infect Dis 5:3. 1973
Gall EA. The histopathology of acute mumps orchitis. Am J Pathol 23:637. 1947
Bjorvatn B: Mumps virus recovered from testicles by fine-needle aspiration biopsy in cases of mumps orchitis. Scand J Infect Dis. 5: 3–7. 1973
Erpenbach K: Systemic treatment with interferon alpha 2B: an effective method to prevent sterility after bilateral mumps orchitis. J Urol. 146: 54–56. 1991
Nixon N, and Lewis DB: Mumps orchitis: surgical treatment. J Urol. 56: 554–560. 1946
Yeniyol CO, Sorguc S, Minareci S, Ayder AR: Role of Interferon-alpha-2B in prevention of testicular atrophy with unilateral mumps orchitis. Urology 55; 6: 931-3, 2000